Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 11 - Number 6
Esophagogastric Cancer: Integration of Targeted Therapies into Systemic Chemotherapy
, 11(6): 681 - 687M. Moehler, S. Schwarz and A. D. Wagner
DOI: 10.2174/156800911796191006
Molecular Targeted Therapy of Gastrointestinal Stromal Tumors
, 11(6): 688 - 697P. Reichardt, A. Reichardt and D. Pink
DOI: 10.2174/156800911796191042
Novel Approaches to Target Pancreatic Cancer
, 11(6): 698 - 713M. Porzner and T. Seufferlein
DOI: 10.2174/156800911796191079
Molecular Targeted Therapy of Hepatocellular Carcinoma – Results of the First Clinical Studies
, 11(6): 714 - 733M. W. Wiedmann and J. Mossner
DOI: 10.2174/156800911796191033
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
, 11(6): 734 - 751P. Goedegebuure, J. B. Mitchem, M. R. Porembka, M. C.B. Tan, B. A. Belt, A. Wang-Gillam, W. E. Gillanders, W. G. Hawkins and D. C. Linehan
DOI: 10.2174/156800911796191024
Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides
, 11(6): 752 - 762B. Aguilar, F. Amissah, R. Duverna and N. S. Lamango
DOI: 10.2174/156800911796191015
α2-Adrenoceptors Enhance Cell Proliferation and Mammary Tumor Growth Acting Through both the Stroma and the Tumor Cells
, 11(6): 763 - 774A. Bruzzone, C. Perez Pinero, P. Rojas, M. Romanato, H. Gass, C. Lanari and I. A. Luthy
DOI: 10.2174/156800911796191051
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
Center for Drug Discovery
University of Houston
Houston, TX
Biography
Biography of Ruiwen Zhang
Ruiwen Zhang is the Robert L. Boblitt Endowed Professor in Drug Discovery and Director of the Drug Discovery Institute at the University of Houston. With over 30 years of experience in the field of biomedical research, particularly in the area of clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH and DoD, and other agencies. He has published more than 230 papers, 2 books, and more than 50 invited reviews/book chapters as well as more than 180 meeting abstracts. For his outstanding contributions in pharmaceutical sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009. Dr. Zhang is recently elected as Fellow of National Academy of Inventors (2018).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net